The New Normal for Health Care Providers (HCPs) and Allied Personnel in Pharmaceutical Industry in Post-Pandemic Era

ABSTRACT

The term 'Health-Care-Providers' (HCPs) include a host of stakeholders. Some of them comprise of doctors, nurses, hospitals, nursing homes, diagnostic-services, pharmacists, other paramedical staff, chemists and druggists besides others. This paper delves into HCPs in Pharmaceutical Industry ranging from pharmaceutical industry ranging from pharma-companies, field sales representatives (or Medical Representatives as they are commonly called), production-personnel, doctors both General Practitioners and Specialists in various domains and tries to examine how working practices have undergone changed, if at all any, during the pandemic in general and predictions for the new normal for them post-pandemic in particular. While pharmaceutical companies during COVID-19 stressed on innovative strategies, digital solutions, strict good manufacturing practices of products including medicines and vaccines complying to norms of sterile facilities and resorted to norms like avoiding contamination through wearing of masks, maintaining social distancing, using sanitizers, a cross-section of doctors during COVID period, started online consultations, advocating telemedicine. It is quite likely that even in post-pandemic era, such practices will continue constituting the new normal's futuristic practices.